0001645113-19-000011.txt : 20191122 0001645113-19-000011.hdr.sgml : 20191122 20191122162240 ACCESSION NUMBER: 0001645113-19-000011 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191120 FILED AS OF DATE: 20191122 DATE AS OF CHANGE: 20191122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOYLE WILLIAM F CENTRAL INDEX KEY: 0001194459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 191241909 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 wf-form4_157445774481944.xml FORM 4 X0306 4 2019-11-20 0 0001645113 NovoCure Ltd NVCR 0001194459 DOYLE WILLIAM F C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 1 1 0 0 Executive Chairman Ordinary Shares 2019-11-20 4 S 0 149300 90.3551 D 660165 D Ordinary Shares 2019-11-20 4 S 0 700 91.01 D 659465 D On November 20, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 149,300 shares in multiple trades at prices ranging from $90.00 to $91.00. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle. By: /s/ Kimberly Burke, Attorney in fact for William F. Doyle 2019-11-22